Expression of apoptosis-regulatory proteins in lesions of pulmonary Langerhans cell histiocytosis

Histopathology

Volumn 45, Issue 1, 2004, Pages 20-28

  Marchal, J ^a   Kambouchner, M ^b   Tazi, A ^b   Valeyre, D ^b   Soler, P ^a  

^a INSERM   (France)

^b AVICENNE HOSPITAL   (France)

Author keywords

Apoptosis; Bcl 2 family proteins; Langerhans cell histiocytosis

Indexed keywords

CASPASE 3; PROTEIN BCL 2; PROTEIN BCL XL; REGULATOR PROTEIN;

ADULT; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL MATURATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPATHOLOGY; DENDRITIC CELL; ENZYME DEGRADATION; FEMALE; HISTIOCYTOSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LANGERHANS CELL; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PULMONARY LANGERHANS CELL HISTIOCYTOSIS; REGULATORY MECHANISM;

EID: 3242767545     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2004.01875.x     Document Type: Article

References (31)

1. Tazi A, Soler P, Hance AJ. Adult pulmonary Langerhans cell histiocytosis. Thorax 2000; 55; 405-416.
2. Kambouchner M, Basset F, Marchal J et al. Three-dimensional characterization of pathologic lesions in pulmonary Langerhans cell histiocytosis. Am. J. Respir. Crit. Care Med. 2002; 166; 1483-1490.
3. Banchereau J, Brière F, Caux C et al. Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000; 18; 767-811.
4. Tazi A, Bonay M, Grandsaigne M et al. Surface phenotype of Langerhans cells and lymphocytes in granulomatous lesions from patients with pulmonary histiocytosis X. Am. Rev. Respir. Dis. 1993; 147; 1531-1536.
5. Colasante A. Poletti V, Rossini S et al. Langerhans cells in Langerhans cell histiocytosis and peripheral adenocarcinomas of the lung. Am. Rev. Respir. Dis. 1993; 148; 752-759.
6. Tazi A, Moreau J, Bergeron A et al. Evidence that Langerhans cells in adult pulmonary Langerhans cell histiocytosis are mature dendritic cells: importance of the cytokine microenvironment. J. Immunol. 1999; 163; 3511-3515.
7. Brabencova E, Tazi A, Lorenzato M et al. Langerhans cells in Langerhans granulomatosis are not actively proliferating cells. Am. J. Pathol. 1998; 152; 1143-1149.
8. Egeler RM, Favara BE, van Meurs M et al. Differential in situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment. Blood 1999; 94; 4195-4201.
9. de Graaf JH, Tamminga RYJ. Kamps WA et al. Langerhans cell histiocytosis: expression of leukocyte cellular adhesion molecules suggests abnormal homing and differentiation. Am. J. Pathol. 1994; 144; 466-472.
10. Matsue H, Takashima A. Apoptosis in dendritic cell biology. J. Dermatol. Sci. 1999; 20; 159-171.
11. Daniel PT, Krammer PH. Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells. J. Immunol. 1994; 152; 5624-5632.
12. Ashany D, Song X, Lacy E et al. Th1 CD4+ lymphocytes delete activated macrophages through the Fas/APO-1 antigen pathway. Proc. Natl. Acad. Sci. USA 1995; 92; 11225-11232.
13. Björck P, Banchereau J, Flores-Romo L. CD40 ligation counteracts Fas-induced apoptosis of human dendritic cells. Int. Immunol. 1997; 9; 365-372.
14. Koppi TA, Tough-Bement T, Lewinsohn DM et al. CD40 ligand inhibits Fas/CD95-mediated apoptosis of human blood-derived dendritic cells. Eur. J. Immunol. 1997; 27; 3161-3165.
15. De Smedt T, Pajak B, Klaus GGB et al. Antigen-specific T lymphocytes regulate lipopolysaccharide-induced apoptosis of dendritic cells in vivo. J. Immunol. 1998; 161; 4476-4479.
16. Pirtskhalaishvili G, Shurin GV, Esche C et al. Cytokine-mediated protection of human dendritic cells from prostate cancer-induced apoptosis is regulated by the Bcl-2 family proteins. Br. J. Cancer 2000; 83; 506-513.
17. Miga AJ, Masters SR, Durell BG et al. Dendritic cell longevity and T cell persistence is controlled by CD154-CD40 interactions. Eur. J. Immunol. 2001; 31; 959-965.
18. Chao DT, Korsmeyer SJ. Bcl-2 family: regulators of cell death. Annu. Rev. Immunol. 1998; 16; 395-419.
19. Kunitake R, Kuwano K, Miyazaki H et al. Expression of p53, p21 and Fas antigen in collagen vascular and granulomatous lung diseases. Eur. Respir. J. 1998; 12; 920-925.
20. Porter AG, Janicke RU. Emerging roles of caspase-3 in apoptosis. Cell Death Diff. 1999; 6; 99-104.
21. Labat-Moleur F, Guillermet C, Lorimier P et al. TUNEL apoptotic cell detection in tissue sections: critical evaluation and improvement. J. Histochem. Cytochem. 1998; 46; 327-334.
22. Petersen BL, Rengtved P, Bank MI, Cartensen H. High expression of markers of apoptosis in Langerhans cell histiocytosis. Histopathology 2003; 42; 186-193.
23. Aicher A, Shu GL, Magaletti D et al. Differential role for p38 mitogen-activated protein kinase in regulating CD40-induced gene expression in dendritic cells and B cells. J. Immunol. 1999; 163; 5786-5795.
24. Savell VH, Sherman T, Scheuermann RH et al. Bcl-2 expression in Langerhans cell histiocytosis. Pediatr. Dev. Pathol. 1998; 1; 210-215.
25. Scheuten B, Egeler RM, Leenen PJ et al. Expression of cell cycle-related gene products in Langerhans cell histiocytosis. J. Pediatr. Hematol. Oncol. 2002; 24; 727-732.
26. Yousem SA, Colby TV, Chen YY, Chen WG, Weiss LM. Pulmonary Langerhans cell histiocytosis. Molecular analysis of clonality. Am. J. Surg. Pathol. 2001; 25; 630-636.
27. Zhang X, Li L, Choe J et al. Up-regulation of Bcl-xL expression protects CD40-activated human B cells from Fas-mediated apoptosis. Cell Immunol. 1996; 173; 149-154.
28. Rabinovich GA, Riera CM. Iribarren P. Granulocyte-macrophage colony-stimulating factor protects dendritic cells from liposome-encapsulated dichloromethylene diphosphonate-induced apoptosis through a Bcl-2-mediated pathway. Eur. J. Immunol. 1999; 29; 563-570.
29. Ludewig B, Graf D, Gelderblom HR et al. Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNF-α, but strongly enhanced by interleukin-10. Eur. J. Immunol. 1995; 25; 1943-1950.
30. Tatsuta T, Cheng J, Mountz JD. Intracellular IL-1β is an inhibitor of Fas-mediated apoptosis. J. Immunol. 1996; 157; 3949-3957.
31. L. Cancer Immunol. Immunother. 2002; 51; 139-144.